We also observed that in renal clear cell carcinoma, by constructing a prognostic model of immune-related genes, screening for six immune-related genes including TIMP3, patients in the high-risk group model had a worse prognosis and the high-risk group was enriched in more immune-related pathways. The gene discussed is TIMP3; the disease is clear cell renal carcinoma.